TORONTO -- (MARKET WIRE) -- April 20, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has expanded its patent portfolio with newly issued patents in Canada and Mexico issued by the Canadian Intellectual Property Office and the Mexican Institute of Intellectual Property, respectively.
